Which one is better for weight loss, Mounjaro or Ozempic/Wegovy? The SURMOUNT-5 trial headline [ntx keto acv gummies review]

Which one is better for weight loss, Mounjaro or Ozempic/Wegovy? The SURMOUNT-5 trial headline [ntx keto acv gummies review]

| 1h 28m 28s | Video has closed captioning.

Headline: SURMOUNT-5 Trial: Tirzepatide vs. Semaglutide for Weight Loss (Non-Diabetic Adults) This video summarizes the key findings from the SURMOUNT-5 trial, comparing the effectiveness of tirzepatide (Mounjaro) and semaglutide (Ozempic/Wegovy) for weight loss in adults with obesity who do not have diabetes. Key Highlights: * Superior Weight Loss: The tirzepatide group achieved a significantly greater average weight loss of 20.2%, compared to 13.7% in the semaglutide group. * Greater Waist Circumference Reduction: Participants on tirzepatide also experienced a larger average reduction in waist circumference (18.4 cm or about 7 inches) compared to the semaglutide group (around 13 cm or about 5 inches). * Conclusion: Tirzepatide (Mounjaro) demonstrated superiority over semaglutide (Ozempic/Wegovy) in reducing both body weight and waist circumference in the studied population. * Safety: Both drugs had acceptable safety profiles, with common gastrointestinal side effects noted. Important Note: This video is for informational purposes only. Consult with your doctor for personalized health advice and treatment options. #SURMOUNT5 #Tirzepatide #Semaglutide #WeightLoss #Obesity #ClinicalTrials #Mounjaro #Ozempic #Wegovy #Health